Hans-Jörg Cordes

High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis

U. Leuschner, Birgit Lindenthal, Günter Herrmann et al. · Hepatology · 2010 · 312 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Stefan Traussnigg, Jörn M. Schattenberg, Münevver Demir et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +10

840 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2a OR -2b PLUS RIBAVIRIN IN THE ROUTINE DAILY TREATMENT OF CHRONIC HEPATITIS C PATIENTS IN GERMANY: THE PRACTICE STUDY

T. Witthoeft, D. Hueppe, C John et al. · Journal of Hepatology · 2008 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +12